Re: Singh et al.: Nepafenac 0.3% after cataract surgery in patients with diabetic retinopathy: results of 2 randomized phase 3 studies (Ophthalmology. 2017;124:776-785) REPLY

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Singh, RP; Lehmann, R; Martel, J; Jong, K; Pollack, A; Tsorbatzoglou, A; Staurenghi, G; Cervantes-Coste Cervantes, G; Alpern, L; Modi, S; Svoboda, L; Adewale, A; Jaffe, GJ

Published Date

  • January 1, 2018

Published In

Volume / Issue

  • 125 / 1

Start / End Page

  • E4 - E6

Published By

Pages

  • 4

Electronic International Standard Serial Number (EISSN)

  • 1549-4713

International Standard Serial Number (ISSN)

  • 0161-6420

Digital Object Identifier (DOI)

  • 10.1016/j.ophtha.2017.07.024

Language

  • English